We studied platelet recovery in 93 patients with myelofibrosis, following an allogeneic hemopoietic stem cell transplant (HSCT). The primary end point of the study was achieving a platelet count of 50x10^9/L within day +100, which occurred in 62 patients (67%) and predicted 5 year non relapse mortality (5% vs 55%; p=0.0009) and 5 year actuarial survival (85% vs 38%; p=.
Sica, S., platelet recovery delay and survival in patients with myelofibrosis undergoing allogenic hemopoietic stem cell transplantation, <<HAEMATOLOGICA>>, 2026; (15): 1-6 [https://hdl.handle.net/10807/336148]
platelet recovery delay and survival in patients with myelofibrosis undergoing allogenic hemopoietic stem cell transplantation
Sica, Simona
Penultimo
Membro del Collaboration Group
2026
Abstract
We studied platelet recovery in 93 patients with myelofibrosis, following an allogeneic hemopoietic stem cell transplant (HSCT). The primary end point of the study was achieving a platelet count of 50x10^9/L within day +100, which occurred in 62 patients (67%) and predicted 5 year non relapse mortality (5% vs 55%; p=0.0009) and 5 year actuarial survival (85% vs 38%; p=.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
